We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Tay-Sachs disease.
- Authors
Gualdrón-Frías, Carlos Andrés; Calderón-Nossa, Laura Tatiana
- Abstract
Introduction: Lysosomal storage disease is caused by the deficiency of a single hydrolase (lysosomal enzymes). GM2 gangliosidoses are autosomal recessive disorders caused by deficiency of β-hexosaminidase and Tay-Sachs disease (TSD) is one of its three forms. Objective: To perform a review of the state of the art on TSD and describe its definition, epidemiology, etiology, physiopathology, clinical manifestations, as well as advances regarding its diagnosis and treatment. Materials and Methods: A literature search was carried out in PubMed using the MeSH terms "Tay-Sachs Disease". Results: after the initial search was conducted, 1 233 results were retrieved, of which 53 articles were finally selected. TSD is caused by the deficiency of the lysosomal enzyme β-hexosaminidase A (HexA), and is characterized by neurodevelopmental regression, hypotonia, hyperacusis and cherry-red spots in the macula. Research on molecular pathogenesis and the development of possible treatments has been limited, consequently there is no treatment established to date. Conclusion: TSD is an autosomal recessive neurodegenerative disorder. Death usually occurs before the age of five. More research and studies on this type of gangliosidosis are needed in order to find an adequate treatment.
- Subjects
LYSOSOMAL storage diseases; HYPERACUSIS; ENZYME deficiency; SPINOCEREBELLAR ataxia; NEURODEGENERATION; DISEASES
- Publication
Revista Facultad de Medicina de la Universidad Nacional de Colombia, 2019, Vol 67, Issue 3, p323
- ISSN
0120-0011
- Publication type
Article
- DOI
10.15446/revfacmed.v67n3.69742